Endometrial Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
SKU : PH2092
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Endometrial Cancer Market ?
Global Endometrial Cancer Market reached USD 18.7 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 27.3 billion by 2031.
Who are the key players in Endometrial Cancer Market?
Major players are Pfizer, AbilityPharma (Ability Pharmaceuticals, SL), Elekta AB, GlaxoSmithKline, Eisai Co., Ltd., ARIAD Pharmaceuticals, Novartis, AstraZeneca PLC, Karyopharm Therapeutics, and Bayer AG.
Related Reports
pharmaceuticalsNeuroendocrine Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
Starting from
$4350
pharmaceuticalsEsophageal Cancer Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 25
Starting from
$4350
pharmaceuticalsOvarian Cancer Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 17
Starting from
$4350
information-communication-and-technologyIndustrial Valve Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 23
Starting from
$4350
information-communication-and-technologyIndustrial Boiler Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 13
Starting from
$4350
medical-devicesAnal Cancer Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 January 02
Starting from
$4350